You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 17, 2025

Details for Patent: 10,925,882


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,925,882 protect, and when does it expire?

Patent 10,925,882 protects ANNOVERA and is included in one NDA.

This patent has fourteen patent family members in fourteen countries.

Summary for Patent: 10,925,882
Title:System for providing birth control
Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.
Inventor(s): Variano; Bruce (White Plains, NY)
Assignee: The Population Council, Inc. (New York, NY)
Application Number:16/827,388
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,925,882: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 10,925,882, titled "System for providing birth control," and provide a detailed analysis of its scope and claims.

Overview of the Patent

Patent Number and Title

United States Patent 10,925,882 B2 is titled "System for providing birth control." This patent was granted on February 23, 2021, and is assigned to the innovators who developed a novel vaginal system for preventing pregnancy.

Inventors and Assignees

The patent lists the inventors and the assignees, which are critical for understanding the ownership and rights associated with the patent. In this case, the assignee is responsible for the commercialization and enforcement of the patent[4].

Claims Analysis

Independent and Dependent Claims

The patent includes a set of claims that define the scope of the invention. These claims are categorized into independent and dependent claims. Independent claims stand alone and define the invention broadly, while dependent claims build upon the independent claims and provide additional details.

  • Independent Claim 1: This claim typically outlines the broadest definition of the invention. For example, in the case of US 10,925,882 B2, the independent claim might describe the overall system for providing birth control, including the components such as progestin and estrogen.
  • Dependent Claims: These claims further specify the invention by adding additional features or limitations. For instance, dependent claims might detail the specific types of progestin and estrogen used, the delivery mechanism, or the dosage regimen[4].

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This is crucial for determining the scope of protection and for infringement analysis. The claims must be clear and definite to avoid ambiguity and ensure that the invention is properly protected.

Scope of the Invention

System Components

The patent describes a vaginal system for preventing pregnancy, which includes a combination of progestin and estrogen. The system is designed to release these hormones over a specified period, providing effective birth control.

  • Progestin and Estrogen: The patent specifies the use of segesterone acetate as the progestin and an estrogen such as ethinyl estradiol. These components are key to the functioning of the system[4].

Delivery Mechanism

The delivery mechanism is another critical aspect of the invention. The patent details how the hormones are delivered through a vaginal ring or other similar device. This mechanism ensures the consistent release of the hormones, maintaining their efficacy.

Prior Art and Patent Landscape

Prior Art Search

Conducting a thorough prior art search is essential to understand the existing technologies and to ensure that the invention is novel and non-obvious. Tools like the USPTO's Patent Public Search and the Common Citation Document (CCD) can be used to identify relevant prior art[1].

Global Dossier

The Global Dossier service provided by the USPTO allows users to view the file histories of related applications from participating IP Offices. This can help in understanding how similar inventions have been treated in different jurisdictions[1].

Legal Status and Enforcement

Patent Status

The legal status of the patent, as indicated by the patent office, is crucial for understanding its enforceability. In the case of US 10,925,882 B2, the patent is listed as active, meaning it is currently enforceable[4].

Potential for Litigation

Understanding the scope and claims of a patent is also important for potential litigation. Companies or individuals may need to assess whether their products or processes infringe on the claims of this patent. This involves a detailed comparison of the accused product or process against the claims of the patent.

Economic and Market Impact

Market Dominance

A patent like US 10,925,882 B2 can provide significant market dominance to the assignee. By excluding others from making, using, or selling the invention, the patent holder can control the market for this specific type of birth control system.

Innovation and Competition

The patent also encourages innovation by providing a financial incentive to the inventors. However, it must be balanced with the need for competition. The scope of the claims should be such that it does not stifle innovation in related areas.

Conclusion

Understanding the scope and claims of United States Patent 10,925,882 is essential for anyone involved in the development, commercialization, or use of similar birth control systems. The detailed analysis provided here highlights the importance of claim construction, prior art search, and the legal status of the patent.

Key Takeaways

  • Claims Analysis: Independent and dependent claims define the scope of the invention.
  • System Components: The patent specifies the use of progestin and estrogen in a vaginal system.
  • Delivery Mechanism: The system delivers hormones through a vaginal ring or similar device.
  • Prior Art and Patent Landscape: Tools like Patent Public Search and Global Dossier are crucial for understanding prior art.
  • Legal Status and Enforcement: The patent is active and enforceable.
  • Economic and Market Impact: The patent provides market dominance and encourages innovation.

FAQs

1. What is the main invention described in US 10,925,882 B2?

The main invention is a vaginal system for preventing pregnancy, which includes a combination of progestin and estrogen.

2. How are the hormones delivered in this system?

The hormones are delivered through a vaginal ring or a similar device designed to release the hormones consistently over a specified period.

3. What tools can be used to conduct a prior art search for this patent?

Tools such as the USPTO's Patent Public Search and the Common Citation Document (CCD) can be used to conduct a prior art search.

4. What is the legal status of US 10,925,882 B2?

The patent is listed as active, meaning it is currently enforceable.

5. How does this patent impact the market for birth control systems?

This patent provides significant market dominance to the assignee by excluding others from making, using, or selling the invention, thereby controlling the market for this specific type of birth control system.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Google Patents - US10925882B2: https://patents.google.com/patent/US10925882B2/en
  5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,925,882

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mayne Pharma ANNOVERA ethinyl estradiol; segesterone acetate RING;VAGINAL 209627-001 Aug 10, 2018 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,925,882

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 120976 ⤷  Try for Free
Australia 2020294780 ⤷  Try for Free
Brazil 112021025853 ⤷  Try for Free
Canada 3141077 ⤷  Try for Free
Chile 2021003410 ⤷  Try for Free
China 114364369 ⤷  Try for Free
Colombia 2021017509 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.